The effects of structural analogs of anandamide in rhesus monkeys discriminating Δ9-tetrahydrocannabinol (Δ9-THC)

被引：0
|
作者：
McMahon, Lance Richard [1 ]
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA
来源：
FASEB JOURNAL | 2007年 / 21卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A410 / A410
页数：1
相关论文
共 50 条
  • [21] The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys
    Justinova, Z
    Tanda, G
    Munzar, P
    Goldberg, SR
    PSYCHOPHARMACOLOGY, 2004, 173 (1-2) : 186 - 194
  • [22] The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys
    Zuzana Justinova
    Gianluigi Tanda
    Patrik Munzar
    Steven R. Goldberg
    Psychopharmacology, 2004, 173 : 186 - 194
  • [23] On the pharmacological properties of Δ9-tetrahydrocannabinol (THC)
    Costa, Barbara
    CHEMISTRY & BIODIVERSITY, 2007, 4 (08) : 1664 - 1677
  • [24] Asymmetric Synthesis of (-)-Cannabidiol (CBD), (-)-Δ9-Tetrahydrocannabinol (Δ9-THC) and Their cis Analogs Using an Enantioselective Organocatalyzed Diels-Alder Reaction
    Pauvert, Yann
    Charette, Andre B.
    ORGANIC LETTERS, 2024, 26 (29) : 6081 - 6085
  • [25] Δ9-tetrahydrocannabinol (Δ9-THC) elicits an intracellular calcium elevation in T cells through the CRAC channels
    Rao, GK
    Kaminski, NE
    FASEB JOURNAL, 2004, 18 (05): : A1148 - A1149
  • [26] Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments
    Wilkerson, Jenny L.
    Schulze, David R.
    Mcmahon, Lance R.
    PLOS ONE, 2019, 14 (03):
  • [27] SR 141716A differentially attenuates the behavioral effects of Δ9-THC in rhesus monkeys
    McMahon, LR
    Amin, MR
    France, CP
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 (5-6): : 363 - 372
  • [28] Vascular effects of Δ9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta
    O'Sullivan, SE
    Kendall, DA
    Randall, MD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 507 (1-3) : 211 - 221
  • [29] Kinetics of the conversion of Δ9-tetrahydrocannabinol to 11-hydroxy-Δ9-THC catalyzed by CYP2C9
    Bland, TM
    Tracy, TS
    Callery, PS
    FASEB JOURNAL, 2004, 18 (05): : A990 - A990
  • [30] Substitution profile of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Δ9-tetrahydrocannabinol
    Joshua A. Lile
    Thomas H. Kelly
    David J. Pinsky
    Lon R. Hays
    Psychopharmacology, 2009, 203 : 241 - 250
12345